Anti-Reflux Infant Formula Market Report 2026

Anti-Reflux Infant Formula Market Report 2026 Market Overview

• Anti-Reflux Infant Formula Market Report 2026 market size has reached to $74.24 billion in 2025 • Expected to grow to $117.14 billion in 2030 at a compound annual growth rate (CAGR) of 9.5% • Growth Driver: Rising Infant Population Driving The Market Due To Increasing Birth Rates And Improved Healthcare Conditions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Anti-Reflux Infant Formula Market?

Anti-reflux infant formula is a specialized baby formula designed to reduce frequent spit-up and regurgitation in infants by making the milk thicker and easier to stay in the stomach. It is usually recommended for babies with gastroesophageal reflux (GER) and should be used only under medical supervision. The main product types of anti-reflux infant formula include thickened formula, pre thickened formula, and specialty formula. Thickened formula refers to infant nutrition products formulated with added thickening agents to reduce regurgitation and reflux symptoms in infants. These products are developed using ingredients such as cow milk based, soy based, protein hydrolysate based, and other ingredients and are designed for age groups including zero to six months, six to twelve months, and twelve to twenty four months. They are distributed through supermarkets or hypermarkets, pharmacies or drug stores, online stores, specialty stores, and others and are used by end users including hospitals and neonatal intensive care units, homecare settings, and pediatric clinics.

What Is The Anti-Reflux Infant Formula Market Growth Forecast?

The anti-reflux infant formula market size is expected to see strong growth in the next few years. It will grow to $117.14 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing development of clinically advanced infant formulas, rising demand for customized nutritional solutions, growing focus on infant gut health management, expansion of premium pediatric nutrition products, increasing investment in specialized infant healthcare products. Major trends in the forecast period include increasing demand for clinically formulated anti-reflux nutrition products, rising preference for hydrolyzed and easy-to-digest ingredients, growing use of specialty formulas for infant digestive health management, increasing adoption of medically supervised infant nutrition solutions, expansion of allergy-specific and reflux-focused infant formulations.

What Are The Drivers Of The Anti-Reflux Infant Formula Market?

The increase in the total number of infants is expected to propel the growth of the anti-reflux infant formula market going forward. An infant is a child from birth up to about one year of age who is fully dependent on caregivers for basic needs and early development. Infant numbers are increasing due to rising birth rates supported by improved healthcare and better living conditions. Anti-reflux infant formula supports infants by making feeds easier to keep down, which helps reduce regurgitation and promotes better nutrient absorption. For instance, in July 2025, according to the Office for National Statistics Census, a UK-based government agency, in 2024, England and Wales recorded 594,677 live births, marking a rise of 3,605 births (0.6%) compared with 591,072 live births in 2023. Therefore, the increase in the total number of infants is driving the growth of the anti-reflux infant formula industry. The rising number of working mothers is expected to propel the growth of the anti-reflux infant formula market going forward. Working mothers are women who have children and are engaged in paid employment, balancing responsibilities of childcare and work outside the home. Working mothers are increasing mainly due to rising living costs that require dual incomes to support household expenses. Anti-reflux infant formula helps working mothers by reducing infants’ spit-up and feeding discomfort, making feeding more predictable and easier to manage during busy work schedules. For instance, in April 2024, according to the Bureau of Labor Statistics, a US-based government agency, the percentage of working mothers with children under the age of 18 was 74% in 2023, up by 1.1 percentage points from the prior year. Therefore, the rising number of working mothers is driving the growth of the anti-reflux infant formula industry. The rising household incomes are expected to propel the growth of the anti-reflux infant formula market going forward. Household income is the total amount of money earned by all members of a household from all sources over a given period, usually a year. Household incomes are increasing mainly due to rising employment opportunities and wage growth, as expanding industries and higher demand for skilled labor lead to more people earning higher salaries and additional income sources. Higher household incomes support the use of anti-reflux infant formula as families are better able to afford specialized and premium infant nutrition products that are often more expensive than standard formulas, enabling improved management of infants’ feeding issues such as reflux. For instance, in October 2024, according to Statistics Iceland, an Iceland-based government agency, household disposable income recorded a 6.6% growth in the second quarter of 2024 compared to the same quarter last year. Therefore, rising household incomes are driving the growth of the anti-reflux infant formula industry.

Key Players In The Global Anti-Reflux Infant Formula Market

Major companies operating in the anti-reflux infant formula market report are Humana GmbH, Nestlé SA, Abbott Laboratories, Danone SA, Reckitt Benckiser Group plc, Royal FrieslandCampina NV, Perrigo Company plc, The Hain Celestial Group Inc, Hero Group AG, HiPP GmbH & Co Vertrieb KG, Richen Nutritional Technology Co Ltd, Kendal Nutricare Ltd, Laboratorios Ordesa SL, Geo-Poland Sp z oo, Fasska Sp z oo, Lactalis Nutrition Santé SAS, Medical Brands Innovations BV, Laboratorios Basi, Sanulac Nutritionals BV, Bellamy's Organic, Bubs Australia, Nannycare

What Defines the Anti-Reflux Infant Formula Market?

The anti-reflux infant formula market consists of sales of rice starch-based anti-reflux formula, carob bean gum-based anti-reflux formula, and extensively hydrolyzed anti-reflux formula. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Anti-Reflux Infant Formula Market Report 2026?

The anti-reflux infant formula market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the anti-reflux infant formula industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.